PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows:wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.

Saved in:
Bibliographic Details
Main Authors ALLISON, Brett Douglas, BARBAY, Joseph Kent, CUMMINGS, Maxwell David, BERTHELOT, Didier Jean-Claude, THURING, Johannes Wilhelmus John Fitzgerald, KREUTTER, Kevin D, DIELS, Gaston, LU, Tianbao, WU, Tongfei, EDWARDS, James Patrick, SHEN, Fang, PHILIPPAR, Ulrike, CONNOLLY, Peter J
Format Patent
LanguageEnglish
French
German
Published 18.09.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows:wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.
Bibliography:Application Number: EP20170851862